These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 4156822)

  • 1. The cyclic AMP system and drug development.
    Smith CG
    Adv Enzyme Regul; 1974; 12():187-203. PubMed ID: 4156822
    [No Abstract]   [Full Text] [Related]  

  • 2. Influence of tricyclic antidepressants on the adenylate cyclase-phosphodiesterase system in the rat cortex.
    Palmer GC
    Neuropharmacology; 1976 Jan; 15(1):1-7. PubMed ID: 176608
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of 2-(4-benzyl-piperidino)-1-(4-hydroxyphenyl)-1-propranolol on adenylate cyclase and 3,5'-cyclic AMP phosphodiesterase in vitro.
    Yamashita Y; Kawai M; Hotta K
    Jpn J Pharmacol; 1976 Jun; 26(3):391-4. PubMed ID: 185445
    [No Abstract]   [Full Text] [Related]  

  • 4. Effects of ethanol on the cyclic AMP system of the dog gastric mucosa.
    Puurunen J; Karppanen H; Kairaluoma M; Larmi T
    Eur J Pharmacol; 1976 Aug; 38(2):275-9. PubMed ID: 182509
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of cyclic AMP pulses on adenylate cyclase and the phosphodiesterase inhibitor of D. discoideum.
    Klein C; Darmon M
    Nature; 1977 Jul; 268(5615):76-8. PubMed ID: 196203
    [No Abstract]   [Full Text] [Related]  

  • 6. Elevation of cyclic nucleotides attenuates ischemia and reperfusion injury of liver.
    Ishikawa H; Jin MB; Suzuki T; Shimamura T; Taniguchi M; Magata S; Furukawa H; Todo S
    Transplant Proc; 2001; 33(1-2):982-3. PubMed ID: 11267156
    [No Abstract]   [Full Text] [Related]  

  • 7. Discovery of new orally active phosphodiesterase (PDE4) inhibitors.
    Ochiai H; Ishida A; Ohtani T; Kusumi K; Kishikawa K; Yamamoto S; Takeda H; Obata T; Nakai H; Toda M
    Chem Pharm Bull (Tokyo); 2004 Sep; 52(9):1098-104. PubMed ID: 15340197
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of motility in immature bovine spermatozoa by cyclic AMP phosphodiesterase inhibitors and seminal plasma.
    Hoskins DD; Hall ML; Munsterman D
    Biol Reprod; 1975 Sep; 13(2):168-76. PubMed ID: 177102
    [No Abstract]   [Full Text] [Related]  

  • 9. Studies on the effect of nicotinamide and ethylnicotinic acid on cyclic AMP phosphodiesterase from rat liver.
    Hoshi Y
    Bull Osaka Med Sch; 1975 Oct; 21(2):77-91. PubMed ID: 181108
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of type-selective inhibitors on cyclic nucleotide phosphodiesterase activity and insulin secretion in the clonal insulin secreting cell line BRIN-BD11.
    Ahmad M; Abdel-Wahab YH; Tate R; Flatt PR; Pyne NJ; Furman BL
    Br J Pharmacol; 2000 Mar; 129(6):1228-34. PubMed ID: 10725272
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An endogenous inhibitor protein of brain adenylate cyclase and cyclic nucleotide phosphodiesterase.
    Wallace RW; Lynch TJ; Tallant EA; Cheung WY
    Arch Biochem Biophys; 1978 Apr; 187(2):328-34. PubMed ID: 208465
    [No Abstract]   [Full Text] [Related]  

  • 12. Cyclic AMP phosphodiesterases of human and rat islets of Langerhans: contributions of types III and IV to the modulation of insulin secretion.
    Parker JC; VanVolkenburg MA; Ketchum RJ; Brayman KL; Andrews KM
    Biochem Biophys Res Commun; 1995 Dec; 217(3):916-23. PubMed ID: 8554616
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of SCH 15280, a new bronchodilator, on cyclic 3',5'-nucleotide phosphodiesterase activity and cyclic 3',5'-adenosine monophosphate levels in guinea pig lung.
    Kreutner W; Sherwood JE
    Biochem Pharmacol; 1977 May; 26(10):951-4. PubMed ID: 193512
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of some phosphodiesterase inhibitors on two different preparations of adenosine 3',5'-monophosphate phosphodiesterase.
    Du Moulin A; Schultz J
    Experientia; 1975 Aug; 31(8):883-4. PubMed ID: 169139
    [No Abstract]   [Full Text] [Related]  

  • 15. Phosphodiesterase 3 (PDE3) attenuates insulin secretion from the human pancreas: a specific PDE3 inhibitor improves insulin secretion in type II diabetes mellitus.
    Okada S; Ohshima K; Mori M
    Endocr J; 2002 Oct; 49(5):581-2. PubMed ID: 12507277
    [No Abstract]   [Full Text] [Related]  

  • 16. Effects of type-selective phosphodiesterase inhibitors on glucose-induced insulin secretion and islet phosphodiesterase activity.
    Shafiee-Nick R; Pyne NJ; Furman BL
    Br J Pharmacol; 1995 Aug; 115(8):1486-92. PubMed ID: 8564209
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of cyclic AMP phosphodiesterase by 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylic acid 3-[2-(N-benzyl-N-methylamino)] ethyl ester 5-methyl ester hydrochloride (YC-93), a potent vasodilator.
    Sakamoto N; Terai M; Takenaka T; Maeno H
    Biochem Pharmacol; 1978; 27(8):1269-74. PubMed ID: 81059
    [No Abstract]   [Full Text] [Related]  

  • 18. Actions of papaverine on intestinal smooth muscle and its inhibition of cyclic AMP and cyclic GMP phosphodiesterases.
    Miyamoto M; Takayanagi I; Ohkubo H; Takagi K
    Jpn J Pharmacol; 1976 Feb; (1):114-7. PubMed ID: 177797
    [No Abstract]   [Full Text] [Related]  

  • 19. Effects of epinephrine and cyclic AMP phosphodiesterase inhibitors on the glycogen synthetic pathway and glucose content in skeletal muscle.
    Haugaard ES; Davidheiser S; Haugaard N
    Biochem Pharmacol; 1976 Feb; 25(4):439-45. PubMed ID: 181002
    [No Abstract]   [Full Text] [Related]  

  • 20. 4-(3-Cyclopentyloxy-4-methoxyphenyl)-2-pyrrolidone (ZK 62711): a potent inhibitor of adenosine cyclic 3',5'-monophosphate phosphodiesterases in homogenates and tissue slices from rat brain.
    Schwabe U; Miyake M; Ohga Y; Daly JW
    Mol Pharmacol; 1976 Nov; 12(6):900-10. PubMed ID: 187926
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.